Rosen Hugh

Rosen Hugh is listed in filings as Director at Regulus Therapeutics Inc.. This profile follows SEC Form 4 activity through Jun 27, 2025, including 10 public disclosures. Recent filings connect the profile to Regulus Therapeutics Inc. (RGLS). The current snapshot covers public activity from Apr 30, 2025 to Jun 27, 2025. Reported amounts are shown as $120.6K to $43.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.